China National Accord Medicines (SZSE:000028) Pre-Tax Income : ¥2,445 Mil (TTM As of Mar. 2024)

View and export this data going back to 1993. Start your Free Trial

What is China National Accord Medicines Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. China National Accord Medicines's pretax income for the three months ended in Mar. 2024 was ¥550 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2,445 Mil. China National Accord Medicines's pretax margin was 2.88%.

During the past 13 years, China National Accord Medicines's highest Pretax Margin was 3.89%. The lowest was 2.89%. And the median was 3.49%.

China National Accord Medicines Pre-Tax Income Historical Data

The historical data trend for China National Accord Medicines's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Accord Medicines Pre-Tax Income Chart

China National Accord Medicines Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Pre-Tax Income

Get a 7-Day Free Trial

1,851.46

2,157.24

1,974.85

2,311.07

2,473.23

China National Accord Medicines Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Pre-Tax Income	Get a 7-Day Free Trial															578.49	713.17	528.80	652.77	550.25

Competitive Comparison of China National Accord Medicines's Pre-Tax Income

For the Medical Distribution subindustry, China National Accord Medicines's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China National Accord Medicines's Pre-Tax Income Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, China National Accord Medicines's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where China National Accord Medicines's Pre-Tax Income falls into.

China National Accord Medicines Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

China National Accord Medicines's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	2499.36	+	0	+	-248.381	+	77.554	+	144.694
	=	2,473

China National Accord Medicines's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	526.506	+	0	+	-54.747	+	-19.236	+	97.726
	=	550

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2,445 Mil.

China National Accord Medicines (SZSE:000028) Pre-Tax Income Explanation

China National Accord Medicines's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	550.249	/	19090.481
	=	2.88%

During the past 13 years, China National Accord Medicines's highest Pretax Margin was 3.89%. The lowest was 2.89%. And the median was 3.49%.

China National Accord Medicines Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of China National Accord Medicines's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

China National Accord Medicines (SZSE:000028) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Accord Medicines Corp Ltd (SZSE:000028) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

200028:China

Address

No. 15, Ba Gua Si 4th Road, Accord Pharmaceutical Building, Futian District, Guangdong Province, Shenzhen, CHN, 518029

Website

http://www.szaccord.com.cn

China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.

China National Accord Medicines (SZSE:000028) Headlines

No Headlines